Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Tokyo  >  DAIICHI SANKYO COMPANY, LIMITED    4568   JP3475350009

SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

DAIICHI S : Notice on Details of the Share Options

share with twitter share with LinkedIn share with facebook
share via e-mail
0
07/12/2011 | 10:20am CEST
For Immediate Release

Company name: DAIICHI SANKYO COMPANY, LIMITED Representative: Joji Nakayama, President and CEO

(Code no.: 4568, First Section of Tokyo, Osaka and Nagoya Stock Exchanges) Please address inquiries to Toshiaki Sai, Corporate Officer, Vice President, Corporate Communications Department

Telephone: +81-3-6225-1126

http://www.daiichisankyo.com/Notice on Details of the Share OptionsTOKYO, Japan (July 12, 2011) Daiichi Sankyo Company, Limited has announced that the subscription amount and other details of its No.5 share options were decided today. As previously announced, the Board of Directors had reached a decision on June 27, 2011 to issue the said share remuneration-type stock options (share options) to remunerate Directors (excluding Outside Directors) and Corporate Officers

1. Name of share options

Daiichi Sankyo Company, Limited No. 5 share options

2. Total number of share options

2,328 share options (100 shares per one share option) Breakdown

Six (6) Directors: 1,102 share options

Eighteen (18) Corporate Officers: 1,226 share options

3. Subscription amount for share options

111,200 yen per share option

(1,112 yen per share)

Reference

Date of Board of Directors resolution: June 27, 2011

###
share with twitter share with LinkedIn share with facebook
share via e-mail
0
React to this article
Latest news on DAIICHI SANKYO COMPANY, LI
12:01p DAIICHI SANKYO : Servier Canada to market edoxaban in Canada
03:08a DAIICHI SANKYO : Enters Into Agreement with Servier Canada For Factor Xa Inhibit..
06/23 DAIICHI SANKYO : Japan Research Foundation for Clinical Pharmacology 9th Annual ..
06/20 DAIICHI SANKYO : Announces Determination of Matters Relating to Acquisition of O..
06/20 DAIICHI SANKYO : to Issue Share Options as Remuneration
06/17 DAIICHI SANKYO : Launches New Generic Drugs Through Its Daiichi Sankyo Espha Sub..
06/16 DAIICHI SANKYO : Findings from Daiichi Sankyo Provide New Insights into Nephrolo..
06/14 DAIICHI SANKYO : Charleston Laboratories, Inc. and Daiichi Sankyo, Inc. Announce..
06/13 DAIICHI SANKYO WEBCAST PRESENTATION : dbVIC - Deutsche Bank ADR Virtual Investo..
06/09 DAIICHI SANKYO : Provides Update on HER3-Lung Study of Patritumab in Non-Small C..
Advertisement
News chart
Full-screen chart
Income Statement Evolution
More Financials